Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women*
Author(s) -
Angela Colbers,
José Moltó,
Jelena Ivanovic,
Kabamba Kabeya,
David Hawkins,
Andrea Gingelmaier,
Graham P. Taylor,
Katharina Weizsäcker,
S Tariq Sadiq,
Marchina van der Ende,
Carlo Giaquinto,
David M. Burger,
André van der Ven,
Adilia Warris,
Jeannine F. Nellen,
Fiona Lyons,
John S. Lambert,
Annette Haberl,
Gerd Faetkenheuer,
Christoph Wyen,
Jürgen K. Rockstroh,
C Schwarze-Zander,
Yvonne Gilleece,
C Wood
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku400
Subject(s) - darunavir , medicine , cmax , ritonavir , pharmacokinetics , dosing , pregnancy , postpartum period , viral load , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy , biology , genetics
To describe the pharmacokinetics of darunavir in pregnant HIV-infected women in the third trimester and post-partum.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom